This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Reducing the Hospital Burden of Hepatic Encephalopathy Through Secondary Prophylaxis

Reducing the Hospital Burden of Hepatic Encephalopathy Through Secondary Prophylaxis

Format

Webcast

Time to Complete

1 hour

Released

July 17, 2017

Expires

July 17, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour (includes 0.50 pharmacotherapy credits)
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider

Jointly provided by Global Education Group and Integrity Continuing Education

Commercial Supporter

Supported by an educational grant from Salix Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America, LLC

Program Description

Cirrhosis is a chronic liver disease stage that results from a variety of causes of liver damage. Liver damage may induce secondary complications such as portal hypertension, esophageal variceal bleeding, spontaneous bacterial peritonitis, and hepatic encephalopathy (HE). HE is a potentially reversible state of impaired cognitive function or altered consciousness in patients with acute or chronic liver disease or portosystemic shunting. The buildup of ammonia in the blood causes brain swelling which leads to the clinical manifestations of HE. The level of neurologic and psychiatric impairment can vary from a subtly altered mental status to a deep coma. HE has been shown to have a substantial burden on patients, their families and caregivers, as well as healthcare utilization. Both the increasing number of patients with cirrhotic liver disease and HE secondary to cirrhosis as well as increasing healthcare costs require that healthcare providers re-evaluate current practice and make any necessary changes to the care of these patients to adapt to these ever-rising trends.

Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.

Intended Audience

This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the burden and need to prevent recurrence and rehospitalizations for overt HE
  • Evaluate the efficacy and safety of available and emerging agents for secondary prophylaxis of HE
  • Utilize management plans that include long-term treatment strategies to care for patients with HE

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty heading below.

Faculty

Robert Rahimi, MD, MSCR
Transplant Hepatology
Baylor University Medical Center
Assistant Professor
Department of Medicine
Texas A&M Health Science Center
College of Medicine
Liver Consultants of Texas
Baylor Charles A. Sammons Cancer Center
Dallas, TX

Dr. Rahimi discloses the following:
Research: Ocera Therapeutics

Planners and Managers Disclosures

The following planners and managers, Andrea Funk, Laura Gilsdorf, Liddy Knight, Ashley Marostica, RN, MSN, and Patima Tanapat, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number: 0530-9999-17-139-H01-P)

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group.

Activity Type: Knowledge

Designated for 0.50 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Global Education Group, and Salix Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Global Education Group, and Salix Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of July 17, 2017 through July 17, 2018, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or hms@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue